LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver (Adv. Mater. 7/2026)

Documenti analoghi

• LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver
  di: Seunghee Kim, et al.
  Pubblicazione: (2025)
• Cholesterol‐DNA Origami Nanostructures for Synthetic Lipid Rafts Induce Early T Cell Activation Signals
  di: Yunmin Jung, et al.
  Pubblicazione: (2026)
• Lipid Nanoparticle‐Mediated CRISPR‐Cas13a Delivery for the Control of Bacterial Infection (Adv. Healthcare Mater. 7/2025)
  di: Bookun Kim, et al.
  Pubblicazione: (2025)
• Programmed Aggregation of Lipidated Nitrobenzoselenadiazole as a Photo‐Activatable Pyroptosis Inducer (Adv. Healthcare Mater. 24/2025)
  di: Jong Min An, et al.
  Pubblicazione: (2025)
• Ultrasound‐Responsive Lipid Nanoparticles for Targeted Therapy and Controlled Drug Release in Non‐Small Cell Lung Cancer
  di: Min Woo Kim, et al.
  Pubblicazione: (2024)